NewAmsterdam Pharma Company N.V. - Wutah pendapatan triwulanan NAMS

NewAmsterdam Pharma Company (NAMS) - logo korporat

NewAmsterdam Pharma (NAMS) is optimizing global supplies of cardiovascular drugs, leveraging a strong team of scientists and regulatory experts. The quarterly revenue growth rate demonstrates income dynamics, while the value of 5395.90 serves as the current metric. The company's developments in combating metabolic disorders and lowering cholesterol are being integrated into care standards, preventing dangerous cardiovascular pathologies.

NAMS Tingkat wutah dodolan sajrone kuartal NewAmsterdam Pharma N.V. (21.06.2023 - 20.11.2026)

Rincian metrik keuangan lan pasar NewAmsterdam Pharma Company N.V. (NAMS)

- kuotasi saiki lan rata-rata prakiraan nilai:
- indikator dhuwit lan arus kas:
Analisis dhasar perusahaan:newamsterdampharma.com - NAMS
Produk seri newamsterdampharma.com

NewAmsterdam Pharma's transition toward the commercialization of statin alternatives for cholesterol management makes quarterly sales volume dynamics a key indicator of business scaling. This metric measures the revenue growth rate for the current quarter relative to the same period last year, allowing investors to distinguish a phase of active expansive growth from a dangerous slowdown in operations prior to a potential correction in asset value.

Analisis pesaing

ASND - Wutah pendapatan kuartal marang kuartal|MDGL: Wutah pendapatan kuartal marang kuartal|CORT: Wutah pendapatan triwulanan|RYTM - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal Akero Corp|Metsera Therapeutics (MTSR) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal moonlaketx.com (MLTX)|Wutah dodolan triwulanan Crinetics Pharmaceuticals CRNX|Wutah pendapatan kuartal marang kuartal Soleno Therapeutics Inc SLNO|Wutah pendapatan triwulanan Amicus Therapeutics Inc FOLD|89bio Corp - Wutah pendapatan triwulanan|Owah-owahan pendapatan dibandhingake kuartal kepungkur Agios Pharmaceuticals Inc (AGIO)|Structure Therapeutics (GPCR) - Wutah pendapatan kuartal marang kuartal|Wutah dodolan triwulanan MiMedx Group, Inc.|Wutah pendapatan kuartal marang kuartal Rezolute Bio|Lexicon Pharmaceuticals, Inc. (LXRX) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan MBX|Wutah dodolan triwulanan Altimmune, Inc. ALT|Wutah pendapatan triwulanan AARD (Aardvark Pharma)|Sagimet Biosciences Inc. (SGMT) - Tingkat wutah pendapatan sajrone kuartal|BIOA: Wutah dodolan triwulanan|Tambahing pendapatan triwulanan BMEA (Biomea Fusion)|QNCX (quincetx.com) - Wutah dodolan triwulanan|Fractyl - Tambahing pendapatan triwulanan|VTVT (vTv Therapeutics Inc) - Wutah pendapatan triwulanan|Agape ATP - Dinamika pendapatan kuartal marang kuartal|Wutah dodolan triwulanan PLUR (Pluri Inc)|Tingkat wutah dodolan sajrone kuartal Synlogic Inc.|Wutah pendapatan kuartal marang kuartal Lipocine Inc. LPCN|Matinas BioPharma (MTNB) - Tingkat wutah pendapatan sajrone kuartal|Spruce Biosciences Inc. - Wutah pendapatan triwulanan|Tingkat wutah dodolan sajrone kuartal Galecto, Inc. GLTO|Carmell Therapeutics (CTCX) - Wutah pendapatan kuartal marang kuartal|Lumos Pharma - Tambahing pendapatan triwulanan|ONVO (Organovo Corp) - Wutah pendapatan triwulanan|Radius Pharmaceuticals (RDUS) - Tingkat wutah dodolan sajrone kuartal